Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MREO US Equity

Mereo BioPharma Group plcHealth Care · Pharmaceutical Preparations · CIK 1719714 · FY ends Dec 31
$0.31
-0.00 (-0.48%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 1 13G
DateEventWhat happened / filerSource
2026-08-198-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by EcoR1 Capital, LLCsec.gov ↗
2026-08-118-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-118-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-118-K 1.01Entry into a material definitive agreementsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-08-11

Every row is a filed document, checked against its EDGAR index.